What is Daxen?
Daxen operates as a vertically integrated powerhouse in the health and wellness industry, specializing in Ganoderma-based products. Founded by Datuk Lim Siow Jin, the company has evolved into a global leader, managing the entire lifecycle of its offerings from cultivation to final distribution. Its product ecosystem spans dietary supplements, functional beverages, personal care, and household goods, supported by a massive network of over 20 million registered distributors across 180 countries. The company's unique business model facilitates seamless international operations, positioning it as a cornerstone of the direct-selling and wellness supplement sectors. Through its commitment to quality and innovative marketing, Daxen has established a formidable brand presence that bridges the gap between traditional health practices and modern consumer demand.
How much funding has Daxen raised?
Daxen has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Daxen
PPP
Public-Private Partnership
What's next for Daxen?
Looking ahead, the strategic allocation of the $150K is expected to focus on scaling digital transformation initiatives and expanding market penetration in emerging economies. With a solid foundation in late-stage operations, Daxen is well-positioned to leverage its existing distributor network to introduce new product lines and enhance its technological capabilities in manufacturing. The company's focus remains on sustaining its growth trajectory while maintaining the high standards of quality that have defined its market leadership for decades. By prioritizing operational excellence and global scalability, Daxen is poised to navigate the complexities of the international wellness market, ensuring long-term value creation for its stakeholders and continued support for its vast network of independent distributors.
See full Daxen company page